Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.

B Escudier, C Porta, P Bono, T Powles, T Eisen, CN Sternberg, JE Gschwend, Giorgi U De, O Parikh, R Hawkins, E Sevin, S Négrier, S Khan, J Diaz, S Redhu, F Mehmud, D. Cella

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)1412-1418
    Number of pages6
    JournalJournal of Clinical Oncology
    Issue number14
    Publication statusPublished - May 2014

    Cite this